Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05317546 · ClinicalTrials.gov registry record · Phase 2
Cannabidiol in Youth Alcohol Use Disorder
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
NCT05317546 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 36 participants.
The verdict
NCT05317546, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
Study Summary
The goal of this study is to test cannabidiol (CBD) as a potentially effective candidate medication for youth alcohol use disorder (AUD). To accomplish this goal, this study will use a randomized, double-blind, within-subjects crossover design. In counterbalanced order, 50 youth (ages 16-22) will receive 600 mg of CBD or placebo three hours before a neuroimaging and behavioral assessment paradigm. The total amount of time the participant will be in the study is approximately one month.
Interventions
- DRUG Cannabidiol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2024-06-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05317546
The ClinicalTrials.gov registry entry for NCT05317546 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cannabidiol is the first listed.
NCT05317546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05317546 about?
NCT05317546 is a clinical study titled "Cannabidiol in Youth Alcohol Use Disorder". The goal of this study is to test cannabidiol (CBD) as a potentially effective candidate medication for youth alcohol use disorder (AUD). To accomplish this goal, this study will use a randomized, double-blind, within-subjects crossover design. In counterbalanced order, 50 youth (ages 16-22) will re...
What is the current status of trial NCT05317546?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2022-10-01. Estimated completion is 2024-06-25.
What interventions are being tested in trial NCT05317546?
The interventions under investigation include: Cannabidiol (DRUG).
Who is sponsoring clinical trial NCT05317546?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.